The Head-to-Head Trial: Retatrutide vs Tirzepatide Direct Everything above relies on comparing results from separate trials with different patients
This gradual titration protocol improves tolerability and is consistent with FDA-approved dosing strategies for weight management [1] [3]
Patients with a history of pancreatitis face substantially higher recurrence risk and should discuss alternative treatments with their healthcare provider, as FDA labeling advises considering other therapies in this population
Through these additional endocrine affects, the synthetic GHS peptides also markedly increase appetite and weight gain, modulate cell proliferation and survival, are cardioprotective, affect heart performance and vascular resistance, are immuno-supportive and anti-arthritic, influence gastric acid secretion and motility, energy/glucose metabolism, as well as exocrine and endocrine pancreatic function
Even 1 to 2 kg of sodium-driven water retention can tip a compensated patient toward clinically apparent ascites